“Machine Learning-Driven Pharmacovigilance Models for Drug-Induced Liver Injury (DILI) Risk Prediction and Personalized Therapeutic Dose Optimization in Chronic Liver Disease Patients”, TSP, vol. 2, no. 3, Aug. 2026, Accessed: Aug. 26, 2026. [Online]. Available: https://www.thesciencepostjournal.com/index.php/tsp/article/view/254